Data from Negative Feedback Regulation of IFN-γ Pathway by IFN Regulatory Factor 2 in Esophageal Cancers

Abstract

<div>Abstract<p>IFN-γ is an antitumor cytokine that inhibits cell proliferation and induces apoptosis after engagement with the IFN-γ receptors (IFNGR) expressed on target cells, whereas IFN regulatory factor 2 (IRF-2) is able to block the effects of IFN-γ by repressing transcription of IFN-γ–induced genes. Thus far, few studies have explored the influences of IFN-γ on human esophageal cancer cells. In the present study, therefore, we investigated in detail the functions of IFN-γ in esophageal cancer cells. The results in clinical samples of human esophageal cancers showed that the level of IFN-γ was increased in tumor tissues and positively correlated with tumor progression and IRF-2 expression, whereas the level of IFNGR1 was decreased and negatively correlated with tumor progression and IRF-2 expression. Consistently, <i>in vitro</i> experiments showed that low concentration of IFN-γ induced the expression of IRF-2 with potential promotion of cell growth, and moreover, IRF-2 was able to suppress IFNGR1 transcription in human esophageal cancer cells by binding a specific motif in IFNGR1 promoter, which lowered the sensitivity of esophageal cancer cells to IFN-γ. Taken together, our results disclosed a new IRF-2–mediated inhibitory mechanism for IFN-γ–induced pathway in esophageal cancer cells: IFN-γ induced IRF-2 up-regulation, then up-regulated IRF-2 decreased endogenous IFNGR1 level, and finally, the loss of IFNGR1 turned to enhance the resistance of esophageal cancer cells to IFN-γ. Accordingly, the results implied that IRF-2 might act as a mediator for the functions of IFN-γ and IFNGR1 in human esophageal cancers. [Cancer Res 2008;68(4):1136–43]</p></div>